, acting in the abVerhage et al., 1991). Whereas rapid evoked SV exosence of CAPS-1, was found to promote desensitization cytosis is essential for fast synaptic transmission, DCV to CAPS-1, and studies of desensitization indicated that exocytosis is slower and mediates the release of transit resulted from decreases in plasma membrane PIP 2 mitters that modulate pre-and postsynaptic events. levels. Moreover, PIP 2 was found to be essential for Mechanisms for SV and DCV exocytosis utilize a number of common components such as SNARE proteins, but CAPS-1 activity and binding to PC12 cell plasma memthere are constituents specific to either pathway that branes. The results indicate that CAPS-1 acts as a PIP 2 may confer kinetic and regulatory properties distinct for binding protein that facilitates DCV exocytosis. Essential each pathway (Rettig and
, acting in the abVerhage et al., 1991). Whereas rapid evoked SV exosence of CAPS-1, was found to promote desensitization cytosis is essential for fast synaptic transmission, DCV to CAPS-1, and studies of desensitization indicated that exocytosis is slower and mediates the release of transit resulted from decreases in plasma membrane PIP 2 mitters that modulate pre-and postsynaptic events. levels. Moreover, PIP 2 was found to be essential for Mechanisms for SV and DCV exocytosis utilize a number of common components such as SNARE proteins, but CAPS-1 activity and binding to PC12 cell plasma memthere are constituents specific to either pathway that branes. The results indicate that CAPS-1 acts as a PIP 2 may confer kinetic and regulatory properties distinct for binding protein that facilitates DCV exocytosis. Essential each pathway (Rettig and Neher, 2002; . prefusion steps in DCV exocytosis involve sequential ATP-dependent synthesis of PIP 2 and the subsequent PIP 2 -dependent action of CAPS-1. Figure 2C ). CAPS-1 antibody reduced the rate of exocytosis trigAt saturating CAPS-1 concentrations, the rate constant gered by Ca 2ϩ alone about 3-fold to close to the rate for DCV exocytosis in permeable cells (k ‫520.0ف‬ s Ϫ1 ; observed following botulinum neurotoxin E treatment Figure 2D ) was the same as that observed in intact PC12 ( Figure 1B, expanded . If CAPS-1 and Ca 2ϩ acted at distinct sequential nearly completely dependent upon prior ATP-depensteps leading to fusion, incubation with one of these dent priming ( Figure 1D due to inactivation of CAPS-1 during the incubation, to supramaximal CAPS-1 concentrations ( Figure 3C ). In this case, CAPS-1 addition at 0, 20, and 120 s following a progressive desensitization of its effects, or to a more general inactivation of the fusion machinery. Ca 2ϩ injection elicited indistinguishable increases in the rates of exocytosis. Thus, supramaximal CAPS-1 conTo determine whether CAPS-1 underwent inactivation during the incubation, we tested the effect of multiple centrations completely compensated for the apparent desensitization observed in incubations with Ca 2ϩ alone. CAPS-1 injections during the incubation ( Figure 3A) . 20 nM CAPS-1 added after Ca 2ϩ elicited an expected inBy varying the CAPS-1 concentration in similar experiments, it was clear that delay of CAPS-1 addition recrease in exocytic rate, and addition of 10 nM CAPS-1 elicited a correspondingly smaller increase in the rate. sulted in desensitization that was characterized by an increased EC 50 for CAPS-1 ( Figure 3D ). These data elimiHowever, the delayed injection of an additional 10 nM CAPS-1 following the initial injection of 10 nM CAPS-1 nate the possibility that general inactivation or depletion of the fusion machinery is responsible for the slowing of prompted no further increase in the rate ( Figure 3A) . These data indicate that CAPS-1 inactivation during the rates during the incubation and provide direct evidence that desensitization to CAPS-1 is the basis for the proincubation was not responsible for the slowing of the secretory rate but rather that desensitization was ocgressive slowing of rates during the time course. curring. Ca Figure 4D ). These data were consistent with the possibility that reductions in PIP 2 were responsible for Ca 2ϩ -dependent desensitization to CAPS-1.
Results

protein. The nervous system dysfunction observed in
To directly assess plasma membrane PIP 2 levels in permeable PC12 cells, we utilized an immunocytochemical assay with PIP 2 antibody to quantitate plasma membrane PIP 2 levels (Aikawa and Martin, 2002). Cells that were not primed with MgATP, which exhibit refractoriness for CAPS-1 activity (see Figure 1D ), contained reduced levels of plasma membrane PIP 2 compared to cells primed with MgATP ( Figures 4E and 4F ). MgATPprimed cells that were further incubated under conditions that result in CAPS-1 desensitization (as in Figure  4A ) exhibited decreases in plasma membrane PIP 2 levels that were accelerated in incubations containing Ca 
Discussion
CAPS-1 Functions as a Priming Factor in DCV Exocytosis
A focus of the current work was to establish the execution point for CAPS-1 in the multistep sequential pathway of DCV exocytosis. We conducted kinetic studies of Ca -triggered fusion step ( Figure 6D ). While the current studies suggest that CAPS-1 funcappears to function at this rate-limiting step, we suggest that CAPS-1 is a priming factor for DCV exocytosis.
tions at a prefusion step in DCV exocytosis, the molecular details of this step are poorly understood. Studies in Evidence that CAPS-1 acts at a step that precedes a final Ca 2ϩ -triggered fusion step was provided by studies chromaffin cells showed that CAPS-1 antibody strongly reduced the number of fusion events but also altered the with inhibitors that disrupt CAPS-1 function, which were progressively ineffective when added at increasing dekinetic properties of residual fusion events ( Figure 1D) . Thus, the current studies further a critical determinant for rapid evoked transmitter or define prefusion events in the DCV pathway as conhormone release in response to Ca 2ϩ elevations. In addisisting of two sequential priming steps, the first requiring tion, the rate of sustained secretion is determined by MgATP and the second requiring Ca 2ϩ and CAPS-1 (Figthe Catecholamine release was detected by RDE voltammetry in 350 and homogenized in a glass dounce homogenizer in PBS containing 0.1% Tween-20, 10 g/ml aprotinin, 10 g/ml leupeptin, and 0.001 l reactions containing ‫01ف‬ 7 permeable cells incubated at 35ЊC in a water-jacketed glass chamber that contained an Ag/AgCl reference M PMSF. The homogenate was centrifuged at 80,000 ϫ g, and the supernatant was applied to a column of Ni-NTA Sepharose. and platinum auxiliary electrode (Earles and Schenk, 1998). A 3 mm glassy carbon disk electrode held in a precision rotator was placed Following washes with 10 column volumes of lysis buffer, 50 column volumes with lysis buffer lacking detergent, and 10 column volumes into the cell suspension and rotated at 3000 rpm to maintain rapid mixing conditions. A potentiostat was used to apply a potential to of 0.01 M imidazole (pH 7.6), 0.25 M NaCl, 10% v/v ethylene glycol, the column was eluted with 0.15 M imidazole (pH 7.6), 0.25 M NaCl. the electrode of ϩ500 mV relative to the Ag/AgCl reference electrode, and the output was processed by using a Tektronix recording Elution buffer was replaced with KGlu by buffer exchange on a PD-10 column (Amersham Pharmacia Biotech). Rabbit antibodies were oscilloscope or a Dataq analog to digital data acquisition system. Catecholamine release was triggered by rapid injection of Ca 2ϩ via generated to recombinant CAPS-1 and purified by conventional methods employing chromatography on protein A-Sepharose (Phara spring-loaded Hamilton syringe. Total catecholamine content of the cells was obtained by injection of Triton X-100 to 0.1%. macia) and affinity columns of CAPS-1 immobilized on Bio-Gel 15 (Bio-Rad Laboratories). With optimal CAPS-1 in Ca 2ϩ triggering reactions, ‫%04ف‬ NE release corresponding to the exocytosis of ‫004ف‬ DCVs/cell was observed. We estimate that release corresponding to the exocytosis UNC-31p/CAPS Mutant Characterization of 10 or fewer DCVs/cell would be readily detected by our assays.
The C. elegans CB714 strain harboring the e714 unc-31 loss-ofIn some assays, we increased cell density to improve detection function allele, generously provided by J. Hodgkin, was grown by to exocytosis of ‫1ف‬ DCV/cell and were unable to detect kinetic standard techniques for preparation of poly(A) ϩ RNA (Krause, 1995). components faster than those reported in the text. Various precondi-RT-PCR was used to generate four amplicons spanning the 4106 tioning studies with Ca 2ϩ subthreshold for triggering exocytosis also nt coding sequences of UNC-31 mRNA. Standard ABI Prism Dye failed to detect more rapid components. Calibrations of release Termination Cycle sequencing reactions were conducted, which curves were conducted by injecting stock solutions of NE. Release identified a single nucleotide substitution (G→A) that changed a curves were background subtracted to eliminate slight signal drops GGA codon (glycine) to GAA (glutamate) corresponding to amino due to addition of Ca 2ϩ . Corrected curves were fit by a single expoacid 538. To introduce the cognate G476E mutation in the rat nential function (see Figure 2B ) using Microcal Origin software (Mi-CAPS-1 protein, a fragment corresponding to nucleotides 1170-crocal Software) and used to obtain time constants and amplitudes 2458 of the coding sequence of the full-length rat CAPS-1 cDNA was of response. Rates of secretion were derived from the first derivaamplified by PCR and cloned into the SmaI site of the pBluescript II tives calculated from the release curves. KS(-) vector. The construct was used as a template for site-directed The extent of secretion was also monitored with an assay that mutagenesis using the Quick Change protocol (Stratagene 
